Using a tiny ball of ice, a minimally invasive interventional radiology treatment called cryoneurolysis safely short circuits chronic pain caused by nerve damage, according to data being presented at the Society of Interventional Radiology’s 38th Annual Scientific Meeting in New Orleans.
Highlights
- By freezing damaged nerves, minimally invasive cryoneurolysis can safely relieve the agonizing chronic pain caused by damaged nerves.
- Nerve-damaged patients said they experienced significant pain relief after treatment, in which a tiny ice ball froze the nerve, short circuiting pain signals sent to the brain.
- More than 15 million Americans suffer from chronic nerve pain, including people with diabetes and cancer.
- Interventional radiologists are physicians who specialize in minimally invasive targeted treatments.
“Cryoneurolysis could have big implications for the millions of people who suffer from neuralgia, which can be unbearable and is very difficult to treat,” said William Moore, M.D., medical director of radiology at Stony Brook University School of Medicine in Stony Brook, N.Y. “Cryoneurolysis offers these patients an innovative treatment option that provides significant lasting pain relief and allows them to take a lower dose of pain medication—or even skip drugs altogether,” added Moore, an interventional thoracic radiologist at Stony Brook.
More than 15 million Americans and Europeans suffer from neuralgia, in which nerves are damaged by diabetes, surgery or traumatic injury, Moore noted. Sufferers often rely on pain medications, which have side effects and may not provide enough relief. Cryoneurolysis uses a small probe that is cooled to minus 10 to minus 16 degrees Celsius, creating a freezer burn along the outer layer of the nerve. This interrupts the pain signal to the brain and blunts or eliminates the pain while allowing the damaged nerves to grow over time, explained Moore.
In the study, 20 patients received cryoneurolysis treatment for a variety of neuralgia syndromes and were evaluated using a visual pain scale questionnaire immediately
after treatment during one-week, one-month and three-month follow-ups after the initial procedure. Prior to treatment, patients’ pain plummeted from an average of 8 out of 10 on the pain scale to 2.4 one week after treatment. Pain relief was sustained for about two months after the procedure. Pain increased to an average of 4 out of 10 on the scale after six months due to nerve regeneration, Moore said. He recommends repeat cryoneurolysis treatments as needed per patient, however, some patients will receive up to a year of pain relief from a single treatment, he said.
The Latest Bing News on:
Chronic pain
- A Predictive Healthcare Visionary Is Optimistic About Solving America’s Opioid Addiction And Chronic Pain Epidemicon April 26, 2024 at 2:20 pm
Studies found that Chronic pain is more prevalent and costly than cancer, diabetes, and heart disease combined, and its rates are rising even as other chronic ...
- Scientists Make Breakthrough in Chronic Pain Treatmenton April 26, 2024 at 7:53 am
Scientists have developed tiny robotic nerve "cuffs" to diagnose and treat neurological disorders. The flexible devices offer a safer, minimally invasive alternative to today's diagnostics and could ...
- Medtronic wins FDA approval for adjustable spine-pain implanton April 26, 2024 at 5:05 am
Medtronic said that the FDA approved its new spinal implant, which delivers a variable electrical pulse to interrupt pain signals before they reach the brain.
- The Challenges of Pain Management in Latin Americaon April 26, 2024 at 1:31 am
New evidence suggested that a section of the Latin American population may have increased sensitivity to pain, which heightens the problem of inadequate healthcare access.
- New Research Links Chronic Pain to Socioeconomic Backgroundon April 25, 2024 at 9:53 pm
New research indicates that the development of chronic musculoskeletal pain may be influenced by factors such as socioeconomic status, fear of movement, smoking, and weaker support networks. In a ...
- FDA Clears Inceptiv, a Closed-Loop Spinal Cord Stimulator for Chronic Painon April 25, 2024 at 5:00 pm
The Food and Drug Administration (FDA) has approved the Inceptiv ™ closed-loop rechargeable spinal cord stimulator (SCS) as an aid in the management of chronic, intractable pain of the trunk and/or ...
- Chronic pain linked to socioeconomic backgroundon April 25, 2024 at 6:08 am
People with a lower socioeconomic background were twice as likely to develop chronic pain following injury, a new study has found.
- From a Kansan with chronic pain: It’s time for our state to embrace medical cannabison April 25, 2024 at 1:33 am
I started feeling sluggish. I felt like I had a fever, even though my temperature never topped 100 degrees. The pain in your skin when you’re feverish, the ache you feel in your joints. I felt ...
- Neuroscientists report a distinct role of touch receptors in treating chronic painon April 23, 2024 at 7:01 am
People often experience the phenomenon of injuring a hand and feeling relief from vigorously shaking it. The mechanism behind this effect is fairly well explained by the "gate control theory" of ...
- Depression linked to chronic pain: Variability shown across patient characteristicson April 23, 2024 at 5:31 am
Chronic pain is a major global disability cause, affecting over 30% of the population and often coexisting with depression, which disables roughly 5% of adults worldwide. The relationship between ...
The Latest Google Headlines on:
Chronic pain
[google_news title=”” keyword=”chronic pain” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
[/vc_column_text]
The Latest Bing News on:
Cryoneurolysis
- Feed has no items.
The Latest Google Headlines on:
Cryoneurolysis
[google_news title=”” keyword=”cryoneurolysis” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]